Willow Biosciences Inc CANSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CANSF is a good fit for your portfolio.
News
-
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF
-
WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC
-
WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS
-
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT
-
Toronto Stocks Flat; Laurentian Bank of Canada Declines on Lower 4Q Profit, Revenue
-
Toronto Stocks Edge Higher; National Bank of Canada Shares Down After Earnings Miss
-
Toronto Stocks Slide; Mogo Shares Rise on Share-Buyback Program
Trading Information
- Previous Close Price
- $0.06
- Day Range
- $0.06–0.06
- 52-Week Range
- $0.05–0.11
- Bid/Ask
- $0.05 / $0.08
- Market Cap
- $8.18 Mil
- Volume/Avg
- 62,000 / 23,446
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 9.23
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 33
- Website
- https://www.willowbio.com
Valuation
|
Metric
|
CANSF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.14 |
Price/Sales | 9.23 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CANSF
|
|---|---|
Quick Ratio | 1.84 |
Current Ratio | 2.30 |
Interest Coverage | −92.67 |
Quick Ratio
CANSF
Profitability
|
Metric
|
CANSF
|
|---|---|
Return on Assets (Normalized) | −108.62% |
Return on Equity (Normalized) | −138.46% |
Return on Invested Capital (Normalized) | −121.12% |
Return on Assets
CANSF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Zsdzdcbmcg | Zvxwvck | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Ycyfkttrg | Qtjr | $68.9 Bil | |
HLN
| Haleon PLC ADR | Tqrhrpfs | Qlq | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dtmgmtqk | Dlv | $14.7 Bil | |
VTRS
| Viatris Inc | Yyxwqrt | Bpjb | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ldlgwsnd | Vqsw | $11.9 Bil | |
CTLT
| Catalent Inc | Kcpfmgdk | Wdvwhh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Fpdxdtsy | Tcs | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Bfyxpvq | Hkjx | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jyhvblby | Ycyggl | $3.5 Bil |